TMO | Thermo Fisher Scientific Inc. Stock Overview

(Stock Exchange: NYSE)

Day's Range	515.00 - 526.43
52 Week Range	493.30 - 627.88
Beta	0.75
Implied Volatility	23.15%
IV Rank	29.43%
Day's Volume	1,417,719
Average Volume	1,708,995
Shares Outstanding	382,500,000
Market Cap	200,449,125,000
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	1980-03-17

Valuation
Profitability
Growth
Health
P/E Ratio	32.86
Forward P/E Ratio	25.00
EPS	15.95
1YR Price Target	685.00
Dividend Yield	0.30%
Dividend Per Share	0.76
Dividend ExDate	2022-09-14
Dividend PayDate	2022-10-14
Employees	122,000
Country	USA
Website	TMO

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).

TMO's peers: A, DHR, EXAS, FLGT, GH, IDXX, ILMN, ME, MTD, WAT, NVTA, CRL, RVTY, TTOO, TWST

*Chart delayed

Analyzing fundamentals for TMO we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is moderate, Growth is very good and Health is strong. For more detailed analysis please see TMO Fundamentals page.

Watching at TMO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on TMO Technicals page.